SCHEMBL28678612

SCHEMBL28678612

O=C(N[C@@H]1CC12CCN(C(=O)OCc1ccccc1)CC2)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 9/20 0.47
▸ HDAC1 Q13547 3/20 0.47
▸ HDAC6 Q9UBN7 3/20 0.47
▸ HDAC8 Q9BY41 1/20 0.47
▸ HDAC3 O15379 2/20 0.46
▸ HDAC2 Q92769 2/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ ATXN2 Q99700 5/20 0.45
▸ KDM1A O60341 2/20 0.45
▸ OPRD1 P41143 1/20 0.44
▸ OPRK1 P41145 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18860226 1.00 ENPP2 (0.47) ENPP2HDAC1HDAC6HDAC8HDAC3
SCHEMBL18838494 1.00 ENPP2 (0.47) ENPP2HDAC1HDAC6HDAC8HDAC3
SCHEMBL31546588 0.93 HDAC1 (0.43) ENPP2HDAC1HDAC6HDAC8HDAC3
SCHEMBL18860325 0.93 HDAC1 (0.43) ENPP2HDAC1HDAC6HDAC8HDAC3
SCHEMBL31546586 0.93 HDAC1 (0.43) ENPP2HDAC1HDAC6HDAC8HDAC3
SCHEMBL28679692 0.93 HDAC1 (0.43) ENPP2HDAC1HDAC6HDAC8HDAC3
SCHEMBL18838340 0.90 SMN1; SMN2 (0.51) ENPP2HDAC1HDAC6HDAC8HDAC3
SCHEMBL18838495 0.89 ENPP2 (0.44) ENPP2HDAC1HDAC6HDAC8HDAC3
SCHEMBL18838370 0.84 NAMPT (0.47) ENPP2HDAC1HDAC6HDAC8HDAC3
SCHEMBL18838396 0.83 KCNH2 (0.48) HDAC1CYP2C19MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3340988-B1 ION CHANNEL INHIBITORY COMPOUNDS, PHARMACEUTICAL FORMULATIONS AND USES AFASCI INC (US) 2025-04-09 — — EP disclosed
CN-108289886-B Ion channel inhibiting compounds, pharmaceutical formulations and uses 安华赛公司 2022-01-28 — — CN disclosed
Send feedback